_version_ 1784604403850805248
author Maillard, Alexis
Redjoul, Rabah
Klemencie, Marion
Labussière Wallet, Hélène
Le Bourgeois, Amandine
D'Aveni, Maud
Huynh, Anne
Berceanu, Ana
Marchand, Tony
Chantepie, Sylvain
Botella Garcia, Carmen
Loschi, Michael
Joris, Magalie
Castilla-Llorente, Cristina
Thiebaut-Bertrand, Anne
François, Sylvie
Leclerc, Mathieu
Chevallier, Patrice
Nguyen, Stephanie
author_facet Maillard, Alexis
Redjoul, Rabah
Klemencie, Marion
Labussière Wallet, Hélène
Le Bourgeois, Amandine
D'Aveni, Maud
Huynh, Anne
Berceanu, Ana
Marchand, Tony
Chantepie, Sylvain
Botella Garcia, Carmen
Loschi, Michael
Joris, Magalie
Castilla-Llorente, Cristina
Thiebaut-Bertrand, Anne
François, Sylvie
Leclerc, Mathieu
Chevallier, Patrice
Nguyen, Stephanie
author_sort Maillard, Alexis
collection PubMed
description
format Online
Article
Text
id pubmed-8616709
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Society of Hematology.
record_format MEDLINE/PubMed
spelling pubmed-86167092021-11-26 Antibody response after 2 and 3 doses of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic cell transplant recipients Maillard, Alexis Redjoul, Rabah Klemencie, Marion Labussière Wallet, Hélène Le Bourgeois, Amandine D'Aveni, Maud Huynh, Anne Berceanu, Ana Marchand, Tony Chantepie, Sylvain Botella Garcia, Carmen Loschi, Michael Joris, Magalie Castilla-Llorente, Cristina Thiebaut-Bertrand, Anne François, Sylvie Leclerc, Mathieu Chevallier, Patrice Nguyen, Stephanie Blood Letters to Blood American Society of Hematology. 2022-01-06 2021-11-26 /pmc/articles/PMC8616709/ /pubmed/34818411 http://dx.doi.org/10.1182/blood.2021014232 Text en Copyright © 2022 American Society of Hematology. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letters to Blood
Maillard, Alexis
Redjoul, Rabah
Klemencie, Marion
Labussière Wallet, Hélène
Le Bourgeois, Amandine
D'Aveni, Maud
Huynh, Anne
Berceanu, Ana
Marchand, Tony
Chantepie, Sylvain
Botella Garcia, Carmen
Loschi, Michael
Joris, Magalie
Castilla-Llorente, Cristina
Thiebaut-Bertrand, Anne
François, Sylvie
Leclerc, Mathieu
Chevallier, Patrice
Nguyen, Stephanie
Antibody response after 2 and 3 doses of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic cell transplant recipients
title Antibody response after 2 and 3 doses of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic cell transplant recipients
title_full Antibody response after 2 and 3 doses of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic cell transplant recipients
title_fullStr Antibody response after 2 and 3 doses of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic cell transplant recipients
title_full_unstemmed Antibody response after 2 and 3 doses of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic cell transplant recipients
title_short Antibody response after 2 and 3 doses of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic cell transplant recipients
title_sort antibody response after 2 and 3 doses of sars-cov-2 mrna vaccine in allogeneic hematopoietic cell transplant recipients
topic Letters to Blood
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616709/
https://www.ncbi.nlm.nih.gov/pubmed/34818411
http://dx.doi.org/10.1182/blood.2021014232
work_keys_str_mv AT maillardalexis antibodyresponseafter2and3dosesofsarscov2mrnavaccineinallogeneichematopoieticcelltransplantrecipients
AT redjoulrabah antibodyresponseafter2and3dosesofsarscov2mrnavaccineinallogeneichematopoieticcelltransplantrecipients
AT klemenciemarion antibodyresponseafter2and3dosesofsarscov2mrnavaccineinallogeneichematopoieticcelltransplantrecipients
AT labussierewallethelene antibodyresponseafter2and3dosesofsarscov2mrnavaccineinallogeneichematopoieticcelltransplantrecipients
AT lebourgeoisamandine antibodyresponseafter2and3dosesofsarscov2mrnavaccineinallogeneichematopoieticcelltransplantrecipients
AT davenimaud antibodyresponseafter2and3dosesofsarscov2mrnavaccineinallogeneichematopoieticcelltransplantrecipients
AT huynhanne antibodyresponseafter2and3dosesofsarscov2mrnavaccineinallogeneichematopoieticcelltransplantrecipients
AT berceanuana antibodyresponseafter2and3dosesofsarscov2mrnavaccineinallogeneichematopoieticcelltransplantrecipients
AT marchandtony antibodyresponseafter2and3dosesofsarscov2mrnavaccineinallogeneichematopoieticcelltransplantrecipients
AT chantepiesylvain antibodyresponseafter2and3dosesofsarscov2mrnavaccineinallogeneichematopoieticcelltransplantrecipients
AT botellagarciacarmen antibodyresponseafter2and3dosesofsarscov2mrnavaccineinallogeneichematopoieticcelltransplantrecipients
AT loschimichael antibodyresponseafter2and3dosesofsarscov2mrnavaccineinallogeneichematopoieticcelltransplantrecipients
AT jorismagalie antibodyresponseafter2and3dosesofsarscov2mrnavaccineinallogeneichematopoieticcelltransplantrecipients
AT castillallorentecristina antibodyresponseafter2and3dosesofsarscov2mrnavaccineinallogeneichematopoieticcelltransplantrecipients
AT thiebautbertrandanne antibodyresponseafter2and3dosesofsarscov2mrnavaccineinallogeneichematopoieticcelltransplantrecipients
AT francoissylvie antibodyresponseafter2and3dosesofsarscov2mrnavaccineinallogeneichematopoieticcelltransplantrecipients
AT leclercmathieu antibodyresponseafter2and3dosesofsarscov2mrnavaccineinallogeneichematopoieticcelltransplantrecipients
AT chevallierpatrice antibodyresponseafter2and3dosesofsarscov2mrnavaccineinallogeneichematopoieticcelltransplantrecipients
AT nguyenstephanie antibodyresponseafter2and3dosesofsarscov2mrnavaccineinallogeneichematopoieticcelltransplantrecipients